News

Latest News

ICYMI: Rubio Joins Hannity

U.S. Senator Marco Rubio (R-FL) joined Hannity to discuss his confrontation with election-denier hypocrisy in the legacy media and the latest on the Trump trial. Watch the full interview on YouTube and...

read more

Rubio Habla con Ninoska Pérez en La Poderosa

“El pueblo cubano sigue siendo un pueblo valiente” El senador estadounidense Marco Rubio (R-FL) habló con Ninoska Pérez en La Poderosa 670 AM, sobre cómo el anhelo de una Cuba libre sigue más vivo que nunca, especialmente hoy el 20 de mayo, en el Día de la...

read more

Rubio, Rosen: ICC’s Overreach is Outrageous

Earlier this month, U.S. Senators Marco Rubio (R-FL) and Jacky Rosen (D-NV) led a bipartisan letter to President Joe Biden urging him to strongly oppose the International Criminal Court’s (ICC) efforts to politically target Israel and respond swiftly and strongly...

read more

Rubio, Florida Republicans Urge HHS to Reverse Decision to Ration Antibody Treatments

Sep 17, 2021 | Press Releases

Miami, FL U.S. Senator Marco Rubio (R-FL) led members of the Florida congressional delegation in urging Department of Health and Human Services (HHS) Secretary Xavier Becerra to reverse course on the department’s sudden decision to ration monoclonal antibody (mAb) drugs for the outpatient treatment of COVID-19, which will cause the State of Florida to face a severe deficit of doses. 
 
“This decision was made without providing the Florida Department of Health or healthcare providers anytime to prepare for this dramatic shift,” the lawmakers wrote. “Prior to this week, health care providers were able to obtain mAb therapies directly from distributors. With no warning, that changed, leaving Florida providers scrambling for information and a path forward for previously scheduled appointments of this life-saving therapy.” 
 
“State Departments of Health cannot develop procedures or plan for problems they are not aware of,” the lawmakers continued. “In the absence of clear, consistent communication, Florida and other states are now facing a situation where they have been denied the opportunity to develop an equitable, efficient state coordinated distribution system. At a time when Florida’s hospitalization rates are rapidly declining, in part because of the State’s successful mAb deployment infrastructure, this is a dangerous reversal of the Department’s stance.”
 
Joining Rubio were Senator Rick Scott (R-FL) and  Representatives Mario Diaz-Balart (R-FL), Gus Bilirakis (R-FL), Bill Posey (R-FL), Carlos Gimenez (R-FL), Scott Franklin (R-FL), and Neal Dunn (R-FL). 
 
The full text of the letter is below. 
 
Dear Secretary Becerra:
 
We write with regard to the Department of Health and Human Service (HHS)’s distribution process for monoclonal antibody (mAb) drugs for the outpatient treatment of COVID-19. On September 13, 2021, with no prior warning, HHS established new allocation procedures that will cause the State of Florida to face a deficit of tens of thousands of doses per week.
 
While these therapies are not a substitute for vaccines, they have prevented thousands of hospitalizations, including in breakthrough cases. It is a benefit that was recognized by President Biden only a week ago when he announced plans to increase the average pace of shipment of mAb therapies by an additional 50 percent. This week’s announcement was dramatically out of step with the change several days later to reduce the amount of Florida and several other states’ allocation without prior notice.
 
This decision was made without providing the Florida Department of Health or healthcare providers any time to prepare for this dramatic shift. Prior to this week, health care providers were able to obtain mAb therapies directly from distributors. With no warning, that changed, leaving Florida providers scrambling for information and a path forward for previously scheduled appointments of this life-saving therapy. 
 
State Departments of Health cannot develop procedures or plan for problems they are not aware of. In the absence of clear, consistent communication, Florida and other states are now facing a situation where they have been denied the opportunity to develop an equitable, efficient state coordinated distribution system. At a time when Florida’s hospitalization rates are rapidly declining, in part because of the State’s successful mAb deployment infrastructure, this is a dangerous reversal of the Department’s stance.
 
We urge HHS to immediately reverse course on this decision.
 
Sincerely,